GSK Reopens its Commercial Operations in the Venezuelan Market in Partnership with Laboratorios Farma


GlaxoSmithKline (GSK), a leading global biopharmaceutical company, has announced the return of its general medicine portfolio starting in September. Among the GSK products available to Venezuelans from September 2023 are treatment lines for infections, urology, respiratory diseases, allergies, central nervous system, and dermatology.

GSK, a British multinational with a global presence of over 200 years, began operations in Venezuela in 1961. Since then, it has developed close ties with the country’s medical community while benefiting Venezuelan patients with products recognized worldwide for their effectiveness and safety in treating and preventing diseases.

“Today, we celebrate the great news that we will make our general medicine products available in Venezuela. We are committed to doing this through a robust supply chain, ensuring quality in every aspect of distribution to ensure that each product reaches the hands of doctors and patients in optimal condition,” commented Alejandro Canakis, General Manager, GSK Central America, the Caribbean, and Venezuela.

Laboratorios Farma, a multinational company of Swiss origin with over 82 years of experience in Venezuela, has been chosen to market GSK products in Venezuelan territory. “We are delighted to have found in Grupo Farma a strong business ally that understands and shares GSK’s ethical values and prioritizes the patients,” commented Erika Gutiérrez, Commercial Director, GSK for Central America, the Caribbean, and Venezuela.

On the other hand, José Carlos Gracia, Vice President of LATAM Operations at Grupo Farma, added, “We are proud to be able to offer quality and proven therapeutic alternatives to Venezuelans. The addition of GSK products to our commercial portfolio strengthens it with globally recognized brands that will once again be available to Venezuelan doctors and patients. This honors and commits us greatly.”

The reactivation will begin with the portfolio of medication for the central nervous system, allergies, and dermatology, and will continue progressively.

About GSK

GSK is a global biopharmaceutical company whose purpose is to unite science, technology, and talent to advance against diseases. Learn more at If you are a healthcare professional, visit us at, where you can find valuable scientific information.

About Grupo Farma

Grupo Farma is a multinational company founded in 1941, with a presence in the Andean and Central American regions. Its mission is to develop, manufacture, market, and represent quality products and services for the health and well-being of consumers, supporting the medical and pharmaceutical community. For more information, visit